Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The dynamic roles of the bladder tumour microenvironment.
Lee YC, Lam HM, Rosser C, Theodorescu D, Parks WC, Chan KS. Lee YC, et al. Among authors: lam hm. Nat Rev Urol. 2022 Sep;19(9):515-533. doi: 10.1038/s41585-022-00608-y. Epub 2022 Jun 28. Nat Rev Urol. 2022. PMID: 35764795 Free PMC article. Review.
NR2F1 controls tumour cell dormancy via SOX9- and RARβ-driven quiescence programmes.
Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, Ekpin E, George A, Zheng Y, Lam HM, Morrissey C, Chung CY, Farias EF, Bernstein E, Aguirre-Ghiso JA. Sosa MS, et al. Among authors: lam hm. Nat Commun. 2015 Jan 30;6:6170. doi: 10.1038/ncomms7170. Nat Commun. 2015. PMID: 25636082 Free PMC article.
Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy.
Winters BR, Vakar-Lopez F, Brown L, Montgomery B, Seiler R, Black PC, Boormans JL, Dall Era M, Davincioni E, Douglas J, Gibb EA, van Rhijn BWG, van der Heijden MS, Hsieh AC, Wright JL, Lam HM. Winters BR, et al. Among authors: lam hm. Urol Oncol. 2018 Jul;36(7):342.e7-342.e14. doi: 10.1016/j.urolonc.2018.03.016. Epub 2018 Apr 12. Urol Oncol. 2018. PMID: 29657089 Free article.
Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer.
Seiler R, Gibb EA, Wang NQ, Oo HZ, Lam HM, van Kessel KE, Voskuilen CS, Winters B, Erho N, Takhar MM, Douglas J, Vakar-Lopez F, Crabb SJ, van Rhijn BWG, Fransen van de Putte EE, Zwarthoff EC, Thalmann GN, Davicioni E, Boormans JL, Dall'Era M, van der Heijden MS, Wright JL, Black PC. Seiler R, et al. Among authors: lam hm. Clin Cancer Res. 2019 Aug 15;25(16):5082-5093. doi: 10.1158/1078-0432.CCR-18-1106. Epub 2018 Sep 17. Clin Cancer Res. 2019. PMID: 30224344 Free article.
A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer.
Makrakis D, Wright JL, Roudier MP, Garcia J, Vakar-Lopez F, Porter MP, Wang Y, Dash A, Lin D, Schade G, Winters B, Zhang X, Nelson P, Mostaghel E, Cheng HH, Schweizer M, Holt SK, Gore JL, Yu EY, Lam HM, Montgomery B. Makrakis D, et al. Among authors: lam hm. Clin Genitourin Cancer. 2023 Apr;21(2):265-272. doi: 10.1016/j.clgc.2022.12.003. Epub 2022 Dec 23. Clin Genitourin Cancer. 2023. PMID: 36710146 Clinical Trial.
256 results